Third, whether the methylation status of LIFR-AS1 functions as an independent diagnostic and prognostic marker for CRC remains to be investigated and requires clinical multicenter studies with larger samples to confirm our findings. The gene discussed is LIFR; the disease is colorectal carcinoma.